Takashi Fujikura | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Takashi Fujikura is active.

Explore More

Publication

Featured researches published by Takashi Fujikura.

The Prostate | 1998

Novel nonsteroidal inhibitor of cytochrome P45017α (17α-hydroxylase/C17-20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats

Yukitaka Ideyama; Masafumi Kudoh; Kyoko Tanimoto; Yoko Susaki; Taiki Nanya; Takahito Nakahara; Hiroko Ishikawa; Toru Yoden; Minoru Okada; Takashi Fujikura; Hideyuki Akaza; Hisataka Shikama

The purpose of this study was to determine the effects of a nonsteroidal C17–20 lyase inhibitor, 2‐(1H‐imidazol‐4‐ylmethyl)‐9H‐carbazole (YM116), on serum concentrations of androgens and ventral prostatic weight in rats.

Archive | 1985

Sulfamoyl-substituted phenethylamine derivatives and process of producing them

Kazuo Imai; Kunihiro Niigata; Takashi Fujikura; Shinichi Hashimoto; Toichi Takenaka

Archive | 1981

Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them

Kunihiro Niigata; Takashi Fujikura

Chemical & Pharmaceutical Bulletin | 1996

Novel potassium channel activators : Synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivatives

Yuzo Matsumoto; Ryuji Tsuzuki; Akira Matsuhisa; Kazuhisa Takayama; Toru Yoden; Wataru Uchida; Masaharu Asano; Shigeo Fujita; Isao Yanagisawa; Takashi Fujikura

Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1995

[Discovery and development of tamsulosin hydrochloride, a new alpha 1-adrenoceptor antagonist].

Toichi Takenaka; Takashi Fujikura; Kazuo Honda; Masaharu Asano; Kunihiro Niigata

Japanese Journal of Pharmacology | 1999

YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, Decreases Adrenal Androgen Synthesis by Inhibiting C17-20 Lyase Activity in NCI-H295 Human Adrenocortical Carcinoma Cells

Yukitaka Ideyama; Masafumi Kudoh; Kyoko Tanimoto; Yoko Susaki; Taiki Nanya; Takahito Nakahara; Hiroko Ishikawa; Takashi Fujikura; Hideyuki Akaza; Hisataka Shikama

Archive | 1977

2-(INDENYLOXYMETHYL) MORPHOLINE DERIVATIVES

Masuo Murakami; Kozo Takahashi; Yuji Kawashima; Tadao Kojima; Kunihiro Niigata; Takashi Fujikura; Yoshihisa Nozaki; Shiro Tachikawa; Shinji Usuda; Soichi Kagami

Archive | 1985